Petros Pharmaceuticals, Inc. (PTPI)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312023-Sep-302023-Jun-302023-Mar-312022-Dec-312022-Sep-302022-Jun-302022-Mar-312021-Dec-312021-Sep-302021-Jun-302021-Mar-31
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q3-FY2023Q2-FY2023Q1-FY2023Q4-FY2022Q3-FY2022Q2-FY2022Q1-FY2022Q4-FY2021Q3-FY2021Q2-FY2021Q1-FY2021
Price to Sales.81x.99x.76x.75x.70x.62x.46x.47x1.11x4.73x7.88x2.89x2.14x5.10x5.60x1.63x2.38x
Price to Book.44x--1.11x.41x.34x.25x.47x.33x1.85x2.83x.60x.50x.89x1.23x1.06x1.58x
Price to Earnings-----------------
Price to Unlevered FCF-----------------
Debt to Asset Ratio.44x.45x.40x1.54x1.70x.85x.64x.65x.63x.82x.55x.49x.48x.45x.33x.36x.47x.66x.66x.68x.75x
Current Ratio2.25x2.22x2.51x.53x.40x.85x1.40x1.60x1.89x3.02x1.65x2.02x2.08x2.36x3.10x2.61x.99x.40x.47x.60x.62x